PharmaShots | Incisive News in 3 Shots

Subscribe Now

Advanced Cholangiocarcinoma

Taiho Oncology's Futibatinib (TAS-120) Receives the US FDA's Breakthrough Therapy Designation for Advanced Cholangiocarcinoma

Taiho Oncology's Futibatinib (TAS-120) Receives the US FDA's Breakthrough Therapy Designation for Advanced Cholangiocarcinoma

April 5, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us